Market Overview

Global Transfection Reagent And Equipment Market to 2022 - Key Players are Thermo Fisher Scientific, Promega, QIAGEN & F.Hoffmann-La Roche

Share:

Global Transfection Reagent And Equipment Market to 2022 - Key Players are Thermo Fisher Scientific, Promega, QIAGEN & F.Hoffmann-La Roche

PR Newswire

DUBLIN, Aug 31, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Transfection Reagent And Equipment Market Size, Share, & Trends Analysis Report By Product, By Method, By Application (Gene Expression, Protein Production, Cancer Research, Therapeutics), And Segment Forecasts, 2014 - 2022" report has been added to ResearchAndMarkets.com's offering.

The global transfection reagent & equipment market size is expected to reach USD 1.08 billion by 2022, progressing at a CAGR of 7.4% during the forecast period.

The growth of the market can be attributed to ongoing oncology-based research & development that aimed at understanding disease cause at genomic & molecular levels coupled with consequent surging demand for targeted therapies.

Transfection technology is recognized as an integral part of research programs pertaining to thorough investigation of various chromosomal anomalies. Hence, rising cancer prevalence of cancer as well as genetic conditions is anticipated to provide a fillip to the market. Furthermore, funds and grants by funding and government bodies are likely to back the growth of the market.

Funding and federal agencies, such as National Science Foundation (NSF), are offering the biotechnology sector with huge funding to carry out their biotechnology-based investigational studies. Moreover, international funding bodies such as NIH and Welcome Trust are projected to play a crucial role in the growth of the market by providing funds for genetic research studies. Such significant funds and grants are poised to boost the adoption of transfection technology over the forecast period.


Further Key Findings From the Report Suggest:

  • On the basis of method, electroporation and liposomal transfection accounted for substantial cumulative share in the market. Several advantages offered by these techniques over other methods in terms of timeliness, complexity, and variability are supplementing the growth of the segment
  • Transfection technology serves a wide range of applications with gene expression studies being the largest application in terms of revenue in 2016
  • North America was the most prominent regional market in 2016. The growth of the region can be attributed to presence of prominent participants coupled with well-established biotechnology & genomic industries
  • Asia Pacific is estimated to post a noteworthy CAGR during the forecast period owing to increasing investments by international players for business expansion and rising buying power of consumers
  • Thermo Fisher Scientific Inc.; Promega Corporation; QIAGEN; and F.Hoffmann-La Roche Ltd are some prominent players in the market. These companies are undertaking several endeavors to enhance their shares in the market

Key Topics Covered:

Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database
2.1.2 Internal database
2.2 Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity flow & bottom up approach
2.4.2 Approach 2: Top down and parent market analysis

Chapter 3 Transfection Reagents & Equipment Industry Outlook
3.1 Market Segmentation
3.2 Market Size And Growth Prospects, 2014 - 2022
3.3 Transfection Reagents And Equipment Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Ongoing R&D in cancer management
3.3.1.2 Implementation of favorable government initiatives & external funding for R&D exercises
3.3.1.3 Development of nanotechnology & drug delivery systems
3.3.1.4 Development in transfection technologies such as nucleofection and magnetofection
3.3.2 Market restraint analysis
3.3.2.1 Concerns to reduce cytotoxicity and immunogenicity
3.3.2.2 Presence of stringent regulatory guidelines
3.4 Key Opportunities Prioritized
3.5 Industry analysis - Porter's
3.6 Transfection Reagents And Equipment PESTEL Analysis

Chapter 4 Transfection Reagents & Equipment Product Outlook
4.1 Global transfection reagents & equipment revenue share, by product, 2014 & 2022
4.2 Transfection reagents
4.2.1 Global transfection reagents market, 2014 - 2022 (USD Million)
4.3 Transfection equipment
4.3.1 Global transfection equipment market, 2014 - 2022 (USD Million)

Chapter 5 Transfection Reagents & Equipment Method Outlook
5.1 Transfection Methods Parameter Comparison
5.1.1 Immunogenicity
5.1.2 Cytotoxicity
5.1.3 Inserts Sizes
5.1.4 Handling Biosafety
5.1.5 Usage Complexity
5.1.6 Protocol Variability
5.1.7 Process Duration
5.1.8 Efficiency
5.1.9 Implementation Costs
5.2 Global transfection reagents & equipment revenue share, by method, 2014 & 2022
5.3 Electroporation
5.3.1 Global electroporation market, 2014 - 2022 (USD Million)
5.4 Liposomes
5.4.1 Global lipofection market, 2014 - 2022 (USD Million)
5.5 Particle Bombardment
5.5.1 Global particle bombardment market, 2014 - 2022 (USD Million)
5.6 Microinjection
5.6.1 Global microinjection market, 2014 - 2022 (USD Million)
5.7 Adenoviral Vectors
5.7.1 Global adenoviral vectors market, 2014 - 2022 (USD Million)
5.8 Calcium Phosphate
5.8.1 Global calcium phosphate market, 2014 - 2022 (USD Million)
5.9 DEAE-Dextran
5.9.1 Global DEAE-dextran market, 2014 - 2022 (USD Million)
5.10 Magnetic Beads
5.10.1 Global magnetic beads market, 2014 - 2022 (USD Million)
5.11 Activated Dendrimers
5.11.1 Global activated dendrimers market, 2014 - 2022 (USD Million)
5.12 Laserfection
5.12.1 Global laserfection market, 2014 - 2022 (USD Million)

Chapter 6 Transfection Reagents & Equipment Application Outlook
6.1 Global transfection reagents & equipment revenue share, by application, 2014 & 2022
6.2 Gene Expression Studies
6.2.1 Global gene expression studies market, 2014 - 2022 (USD Million)
6.3 Protein Production
6.3.1 Global protein production market, 2014 - 2022 (USD Million)
6.4 Transgenic Models
6.4.1 Global transgenic models market, 2014 - 2022 (USD Million)
6.5 Therapeutic Delivery
6.5.1 Global therapeutic delivery market, 2014 - 2022 (USD Million)
6.6 Cancer Research
6.6.1 Global cancer research market, 2014 - 2022 (USD Million)
6.7 Biomedical Research
6.7.1 Global biomedical research studies market, 2014 - 2022 (USD Million)

Chapter 7 Transfection Reagents & Equipment Regional Outlook

Chapter 8 Competitive Landscape

  • Thermo Fisher Scientific Inc
  • Promega Corporation
  • Lonza AG
  • Qiagen
  • Mirus Bio LLC
  • EMD Millipore
  • Bio-Rad Laboratories Inc.
  • OriGene Technologies Inc.
  • Merck KgaA

For more information about this report visit https://www.researchandmarkets.com/research/434b24/global?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



Cision View original content with multimedia:http://www.prnewswire.com/news-releases/global-transfection-reagent-and-equipment-market-to-2022---key-players-are-thermo-fisher-scientific-promega-qiagen--fhoffmann-la-roche-300704845.html

SOURCE Research and Markets

View Comments and Join the Discussion!